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Abstract Tyrophagus putrescentiae and Dermatophagoides
pteronyssinus are causative factors for the development of
airway hypersensitivity. The main objective in this study
was to identify the cross-reactive allergens between T.
putrescentiae and D. pteronyssinus and investigate their
sensitization in patients with allergic rhinitis. The
prevalence of sensitization to mites was determined by skin
prick tests and histamine release assays. Both immunoblot
and ELISA inhibition assays were performed by using the
recombinant allergens of T. putrescentiae and D. pteronys-
sinus. The cross-reactive allergens were identified by using
IgE-binding inhibition analysis. The correlations of specific
IgE between T. putrescentiae and D. pteronyssinus to group
2 and group 3 mite allergens were compared. A total of 117
allergic rhinitis patients, aged between 16 and 40 years old
were recruited to be included in this study. The results
showed that 70% (82/117) of allergic rhinitis subjects had
skin test positive reactions to D. pteronyssinus or T.
putrescentiae. Among these mite-sensitive subjects, there
were 81 subjects (81/82) sensitive to D. pteronyssinus and
34 subjects (34/82) sensitive to T. putrescentiae. Among the
T. putrescentiae hypersensitive subjects, 97% (33/34) were
also sensitized to D. pteronyssinus. In the IgE-binding
inhibition analysis, 59% (13/22) subjects had IgE-binding
activity of T. putrescentiae that was completely absorbed by
D. pteronyssinus, especially components with MW at
16 kDa. In ELISA inhibition testing, 69% of IgE-binding
was inhibited by rTyr p 2, and 45% inhibited by rTyr p 3.
The titers of IgE antibodies to rTyr p 2 and rDer p 2 were
well correlated, but not rTyr p 3 and rDer p 3. In
conclusion, most T. putrescentiae sensitized subjects were
also sensitized to D. pteronyssinus in young adult allergic
rhinitis patients. The complete absorption of IgE binding
activity by D. pteronyssinus indicates that T. putrescentiae
hypersensitivity might be due to the cross-reactivity, not
dual-sensitization of D. pteronyssinus and T. putrescentiae.
The IgE-binding titers of group 2 allergens were well
correlated and the binding activity of Tyr p 2 could be
absorbed by Der p 2, suggesting that group 2 allergens are
the major cross-reactive allergen of D. pteronyssinus and T.
putrescentiae.
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Introduction
There is increasing evidence that sensitization to indoor
allergens is a causative factor for the development of airway
hypersensitivity among people who are genetically predis-
posed to making IgE antibody responses [1–3]. More than
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60,000 species of mites have been described from various
regions of the world; the most prevalent and well-investigated
indoor perpetual allergen sources are domestic mites in
tropical, subtropical, and humid areas [4, 5]. According to
their abundance and allergenic importance, domestic mites
are classified into two categories, Pyroglyphid and non-
Pyroglyphid mites, commonly referred to as house dust
mites and storage mites [6, 7], respectively. House dust mites
(Dermatophagoides pteronyssinus and Dermatophagoides
farinae) and storage mites (Blomia tropicalis and Tyrophagus
putrescentiae) occur with high frequency and at high levels of
infestation in houses around the world [7–9], including North
America (USA) [10], Europe (Spain, Holland, and UK) [11],
and Asia (Korea, Singapore, and Taiwan) [12, 13]. Our
epidemiologic research with regards to allergic rhinitis and
asthmatics has shown that sensitization to these mites is
associated strongly with airway hypersensitivity [14].
Dermatophagoides pteronyssinus is the major cause of
allergy in more than 80% of allergic patients with bronchial
asthma in Taiwan [15], and the major allergens of D.
pteronyssinus have been identified as Der p 1, Der p 2, and
Der p 3 [16]. Recently, storage mites have been reported to be
clinically important allergenic components of dust samples
throughout the world, supporting their clinical significance
[17]. In our previous report, we demonstrated that 63% of
asthmatic patients had concurrent sensitization to storage mite-
B. tropicalis and house dust mite-D. pteronyssinus by skin
tests, and the extent of cross-reactivity between Blo t 5 and
Der p 5 was estimated at 33% to 43% by IgE inhibition [18].
This suggests that several IgE-binding proteins of storage
mites are cross-reactive components, which can be inhibited
by D. pteronyssinus, but the others are species-specific
allergens [18]. However, which allergenic components belong
to the cross-reactive or species-specific allergens between D.
pteronyssinus and T. putrescentiae remains unclear and needs
to be investigated in more detail.
Although it is well known that T. putrescentiae can cause
allergic respiratory symptoms after occupational exposure in
farms and grain elevator stores, currently, more attention is
being paid to its allergenicity in non-occupational environ-
ments. At least 20 IgE-binding allergenic components of T.
putrescentiae have been detected [19]. So far, only five
allergens have been cloned and characterized, and the major
allergens have been identified as Tyr p 2 and Tyr p 3 [13, 20].
The objectives of this study were to investigate the
relationship between T. putrescentiae and D. pteronyssinus
allergy in allergic rhinitis individuals using skin prick tests,
basophil histamine release assays in vitro, and specific IgE
measurements. Immunoblot inhibition was used to evaluate
the cross-reactivity between T. putrescentiae and D.
pteronyssinus and to identify components of cross-reacting
allergens and species-specific allergens. The major recom-
binant allergens were also cloned, expressed, and purified
to detect the titers of specific IgE. The correlation of IgE
responses to group 2 or group 3 allergens among T.
putrescentiae and D. pteronyssinus were also investigated.
Methods
Study Subjects
A total of 117 allergic rhinitis subjects (70 males and 47
females) who attended the Clinic in the Division of Allergy,
Immunology, and Rheumatology at Taichung Veterans
General Hospital were recruited for this study. The subjects
who had allergic rhinitis were defined as having a history of
recurrent nasal stuffiness, sneezing, and rhinorrhea, which
were associated with exacerbation resulting from allergens
exposure. The ages of these subjects ranged from 16 to
40 years old (with a mean age of 28±10.5). The healthy
volunteers (H1 and H2) with negative responses to D.
pteronyssinus by skin prick tests and specific IgE measure-
ments were selected as negative controls. Written informed
consent was obtained from each participant before being
enrolled in the study. The Institutional Review Board of
Taichung Veterans General Hospital reviewed and approved
the ethical issues of this study. Blood samples were drawn
and sera were stored for the measurement of specific IgE to
T. putrescentiae and D. pteronyssinus. Among the 117
allergic rhinitis subjects, there were 33 patients with positive
prick test to both D. pteronyssinus and T. putrescentiae
mites. Among these 33 mite-sensitive patients, only 30 cases
donated blood samples for sera collection to examine the
relationship of IgE titers by ELISA. Unfortunately, only 22
cases had enough sera for all assays.
Skin-prick Testing
All allergic rhinitis patients were selected for skin-prick
testing. The skin of the forearm was pricked with T.
putrescentiae and D. pteronyssinus using a disposable
lancet (Greer Derma Pit system; Greer Laboratories, Lenoir,
NC, USA) at the concentration of 100 μg/ml following the
endpoint titration. Histamine (10 mg/ml, Sigma, St. Louis,
MO, USA) and phosphate-buffered saline (PBS, pH 7.2)
were used as positive and negative controls, respectively.
The responses were observed after 15 min and a wheal
3 mm in diameter greater than negative control was
considered a positive result.
Preparation Crude Extracts and Recombinant Allergens
of T. putrescentiae and D. pteronyssinus
The preparation of D. pteronyssinus and T. putrescentiae
mite crude extracts was described previously [21]. In brief,
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crude extracts of D. pteronyssinus were prepared from
lyophilized whole mite bodies purchased from Allergon
(Angelholm, Sweden). Tyrophagus putrescentiae mites
were cultured in our laboratory with a medium consisting
of yeast extract and mouse chow, and then mite bodies were
separated from the medium. Separation of the mites from
the medium was achieved by gently stirring the medium
with a glass rod following overnight culture. The mites that
migrated to the cover were collected. This collection
included a great proportion of mite bodies and was almost
free of medium. Frozen T. putrescentiae mites were
homogenized and extracted with PBS. Protein concentra-
tion was determined by the Bradford assay (Bio-Rad,
Hercules, CA, USA) using bovine serum albumin as a
standard.
The recombinant allergens of T. putrescentiae (rTyr p 2
and rTyr p 3), D. pteronyssinus (rDer p 2 and rDer p 3), and
D. farinae (rDer f 1 and rDer f 2) were prepared and used to
analyze the relationship of IgE reactivity [13, 20, 22–25].
Total RNA of mites was isolated with Trizol reagent and
cDNA was synthesized with primer dT17, MMLV reverse
transcriptase (Gibco-BRL, New York, NY, USA). The
specific primers were designed based on the accession number
in the National Center for Biotechnology Information, Tyr p 2
(O02380) and Tyr p 3 (EU302595). The PCR products were
ligated into a pQE30 vector and transformed into Escherichia
coli-M15. Transformants were selected by kanamycin
(25 μg/ml) and ampicillin (100 μg/ml). Expressions of re-
combinant allergens were performed according to the methods
described in the QIA ExpressionistTM Kit manufacturer's
directions (Qiagen, Hilden, Germany). The recombinant
proteins were expressed as a 6× His-tagged protein using
1 mM isopropyl-β-D-thiogalactopyranoside (Promega,
Madison, WI, USA) induction. The proteins were purified
by nickel-nitrilotriacetic acid agarose metal affinity column
chromatography under native conditions.
Determination of IgE Antibodies in Sera Against
T. putrescentiae and D. pteronyssinus Crude Extracts
A total of 22 allergic subjects positive to T. putrescentiae and
D. pteronyssinus by skin prick test were selected for further
analysis, including enzyme-linked immunosorbent assay
(ELISA), immunoblot, and histamine release assay. The
IgE antibodies against T. putrescentiae and D. pteronyssinus
crude extracts in sera determined by an ELISA were
described previously [21]. Mite crude extracts (5 μg/ml)
were diluted with coating buffer 0.1 M NaHCO3 (pH 8.4)
(100 μl/well) and coated to plates, incubated overnight with
diluted (1:5) sera at 4°C. The alkaline phosphatase (AP)-
conjugated mouse anti-human IgE antibodies were diluted
(1:2,000) (Southern Biotech Association, Birmingham, AL,
USA) and added for detection the human IgE. The bound
enzyme substrate was detected using r-nitrophenyl phosphate
(Kirkegaard and Perry, Gaithersburg, MD, USA). The
reaction was stopped after 30 min and the optical density
measured at 405 nm. Ten normal healthy individuals that had
negative skin test results to both T. putrescentiae and D.
pteronyssinus mite crude extracts were selected from our
hospital staff. The negative cut-off values were defined as
values below mean ±2 standard deviations; the specimen of
T. putrescentiae exceeding 0.21±0.04 units or specimen of
D. pteronyssinus exceeding 0.24±0.04 units was considered
as a positive reaction.
IgE ELISA Reactivity and Inhibition Assays
with Recombinant Allergens
The IgE antibodies against recombinant allergens in serum
samples were detected by ELISA. The preliminary test
showed that the optimal level of absorption could be
obtained by coating a plate with 5 μg/ml recombinant
allergen in 0.1 M NaHCO3, pH 8.4. One hundred
microliters of diluted (1:5) human sera was added and
incubated overnight at 4°C. Plates were washed and
incubated with AP-conjugated mouse anti-human IgE
antibodies diluted 1:2,000 in PBST (phosphate-buffered
saline, 1% Triton X-100, pH 7.2) for 1 h at room
temperature. The colorimetric reaction was presented by
r-nitrophenyl phosphate and stopped after 30 min and the
optical density measured at 405 nm. The cut-off value was
mean ±2× standard deviation as 0.23±0.02 unit of the sera
of 10 healthy volunteers who did not have a history of
allergic symptoms, and samples exceeding 0.25 unit were
considered as positive. The titers of antigen-specific IgE
were further classified as follows: OD405nm≤0.25 of
titer “−”; OD405nm: 0.25∼0.34 of titer “1±”; OD405nm:
0.35∼0.44 of titer “2±”; OD405nm: 0.45∼0.54 of titer “3±”;
OD405nm: 0.55∼0.64 of titer “4±”; OD405nm: 0.65∼0.74 of
titer “5±”; OD405nm≥0.75 of titer “6±”. For the IgE ELISA
inhibition assay, each serum sample was pre-incubated with
50 μl of rTyr p 2 or rTyr p 3 (50 μg/ml), then left overnight
at 4°C and subsequently reacted with 5 μg/ml of Tp extract
coated on the plates. The following processes for determining
IgE antibodies by ELISA are the same as those described
previously.
Immunoblot Analysis
For the analysis of the components recognized by IgE
antibodies, protein components of mite extracts were separated
by SDS-PAGE and immunoblot analysis of T. putrescentiae
allergenic components as previously described [21]. In brief,
T. putrescentiae crude extract was transferred onto a
polyvinylidene difluoride (PVDF) membrane. After blocking,
the blots were incubated with diluted serum (1:5) at 4°C for
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16 h. The membranes were incubated with AP-conjugated
monoclonal antihuman IgE antibodies at room temperature for
2 h. The blots were developed in a substrate solution for
30 min and the antigen-antibody binding was recorded
photographically.
Each serum sample (100 μl) was pre-incubated with
50 μl of D. pteronyssinus crude extracts or recombinant
allergen rDer p 2, rDer p 3 (50 μg/ml) and left overnight at
4°C. After the pre-absorption, the subsequent procedures
for determining IgE by immunoblot were the same as those
described previously. Furthermore, five subjects (B6, B9,
B12, B14, and B17) who had IgE antibodies against Tp
extracts with MWs both of 16 and 26 kDa were selected for
inhibition immunoblots with 50 μl of rDer p 2 or rDer p 3
(50 μg/ml).
Basophil Histamine Release Assay
The sera from the allergic rhinitis patients (B1∼B22) and
healthy volunteers (H1 and H2) were selected for basophil
histamine release assay, and the selection of these subjects
was described above. Washed polymorphonuclear cells were
obtained from the venous blood of non-atopic donors using
PolymorphpretTM solution (Axis-Shield, Oslo, Norway). The
cells were resuspended in medium RPMI-1640 by adjusting
to 2×106 cells/ml using trypan blue assessment. Passive
sensitization of basophils with specific IgE from the subject
sera (B1∼B22) was performed for 4 h at 37°C. The
sensitized cells were triggered with 50 μg/ml of allergen
for 30 min at 37°C, and then the supernatant was collected
and reacted with O-phthalaldehyde (OPA, 5 mM) for 7 min
[26]. The reaction was stopped by adding H2SO4 (0.04 M).
The histamine released into the supernatant was measured by
a fluorescence spectrophotometer. The percentage of
histamine release was calculated by the following formula:
(stimulated released histamine − spontaneous released
histamine) / total released histamine × 100%.
Statistical Analysis
The SPSS Sample Power 2.0 was used for power
calculation analysis. Statistical comparisons of the mite-
triggering histamine release between D. pteronyssinus and
T. putrescentiae were performed by paired t test. Statistical
comparisons of the histamine release between allergic
rhinitis patients or healthy volunteers were performed by
student's t test. Two-tailed p values lower than 0.05 were
considered to be statistically significant.
Results
The Prevalence of Sensitization to D. pteronyssinus
and T. putrescentiae
The sensitization to D. pteronyssinus and T. putrescentiae
was determined by skin prick tests. The results showed that
70% (82/117) of allergic subjects were sensitized to either
D. pteronyssinus or T. putrescentiae. There were more
subjects sensitized to D. pteronyssinus, 69% (81/117) than
to T. putrescentiae 29% (34/117), and 28% (33/117) of the
subjects were sensitive to both D. pteronyssinus and T.
putrescentiae. Among the T. putrescentiae-sensitive allergic
subjects, 97% (33/34) of the subjects were also sensitive to
D. pteronyssinus, with only one subject being sensitized to
T. putrescentiae alone.
Fig. 1 The percentage of histamine release from basophils. The
basophils were pre-sensitized by sera from subjects with allergic
rhinitis and healthy volunteers were then triggered by T. putrescentiae
or D. pteronyssinus at a concentration of 50 μg/ml. Tp (open bars):
crude extract of T. putrescentiae; Dp (closed bars): crude extract of D.
pteronyssinus, B1–B22: allergic rhinitis subjects, H1–H2: normal
subjects
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Different Percentages of D. pteronyssinus- and T.
putrescentiae-Triggered Histamine Release by Basophils
After Sensitization with Sera
A total of 24 samples, 22 from allergic rhinitis patients
(B1–B22) and two from non-allergic healthy volunteers
(H1 and H2) were used for the basophil histamine release
assay. When the basophils were pre-incubated with the sera
(H1 and H2) and then triggered by T. putrescentiae or D.
pteronyssinus, the mean percentage of baseline histamine
release was 9.0±3.5 % (7.8–13.6%). While the basophils
pre-incubated with sera (B1∼B22), the percentage of
histamine release was compared between T. putrescentiae
and D. pteronyssinus challenge. The results show that the
mean percentage of histamine release triggered by D.
pteronyssinus was apparently higher than T. putrescentiae
(78.6±10.4% vs. 45.2±14.2%; p<0.001) (Fig. 1).
The Prevalence of Sensitization to the Crude Extracts
and Major Allergens of D. pteronyssinus
and T. putrescentiae
The results of ELISA with D. pteronyssinus and T.
putrescentiae crude extracts reactive to sera from the 22
subjects (B1∼B22) are shown in the Table I. Further, these
22 sera were performed for analysis of the major allergen
sensitization. The major allergens were determined by
specific IgE measurement against rDer f 1, rDer f 2, rDer
p 2, rTyr p 2, rDer p 3, and rTyr p 3. The results showed
that 82% (18/22) of subjects were sensitive to rDer p 2 and
more subjects were sensitized to group 2 allergens than
group 1 (rDer f 1; 59%) or group 3 allergens (rDer p 3;
55%). There were also more subjects that were sensitized to
group 2 allergens of D. pteronyssinus (82% for rDer p 2)
than to D. farinae (77% for rDer f 2) and T. putrescentiae
(73% for rTyr p 2) (Table II).
Identification of T. putrescentiae Specific Allergenic
Components by IgE Immunoblot Inhibition
with D. pteronyssinus
The same 22 sera were selected for IgE immunoblot
inhibition, and a PVDF membrane of the T. putrescentiae
crude extract was used to identify T. putrescentiae specific
allergens reacting with the sera after the absorption of D.
pteronyssinus. The results of immunobot for T. putrescen-
tiae and immunoblot inhibition with D. pteronyssinus are
shown in Fig. 2a; 59% (13/22) of the subjects possessed the
No. of cases allergic rhinitis subjects Tp Dp No. of cases healthy volunteers Tp Dp
B1 0.67a 0.83 C1 0.18 0.31
B2 0.45 0.62 C2 0.17 0.22
B3 0.56 0.62 C3 0.27 0.26
B4 0.66 0.89 C4 0.16 0.23
B5 0.37 0.52 C5 0.18 0.18
B6 1.21 1.67 C6 0.22 0.19
B7 0.75 0.84 C7 0.21 0.25
B8 0.34 0.62 C8 0.23 0.27
B9 1.31 1.62 C9 0.22 0.26
B10 1.26 1.34 C10 0.26 0.24
B11 0.36 0.52
B12 1.73 1.84
B13 0.52 0.84
B14 1.01 1.24
B15 0.67 0.84
B16 0.85 0.96
B17 1.41 1.65
B18 1.35 1.63
B19 0.76 1.22
B20 0.87 1.42
B21 0.94 1.21
B22 0.74 0.89
Mean 0.85 1.08 Mean 0.21 0.24
SD 0.38 0.41 SD 0.04 0.04
Table I The Titers of
Mite-Specific IgE in the Sera
a Absorbance was measured at an
optical density of 405 nm
Dp D. pteronyssinus, Tp T.
putrescentiae
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IgE-binding components of T. putrescentiae, which could
be completely absorbed by D. pteronyssinus. Eighteen out
of 22 sera possessed an IgE-binding component with a MW
of 16 kDa, except for patients B5, B7, B8, and B11. The
IgE-binding component with a MW of 16 kDa could be
totally absorbed by D. pteronyssinus from the sera of these
16 patients and partially absorbed from sera B12 and B20.
The results indicate that this allergenic component showed
a high level of cross-reactivity between D. pteronyssinus
and T. putrescentiae. Six out of 22 subjects possessed an
IgE-binding component with a MW of 26 kDa, which was
not absorbed by D. pteronyssinus in four sera (B1, B3, B6,
and B12) or partially absorbed in two sera (B14 and B17),
indicating that this component might be a T. putrescentiae
specific allergen (Fig. 2a). Five sera from subjects who had
positive reactions to the IgE-binding component of T.
putrescentiae with MWs of 16 and 26 kDa were selected
for further analysis. These five sera were absorbed by either
rDer p 2 or rDer p 3, followed by IgE immunoblot assay.
The results show that all the T. putrescentiae IgE-binding
components of 16 kDa could be absorbed by rDer p 2 and
components of 26 kDa could not be absorbed by rDer p 3
(Fig. 2b). The complete absorption of the 16 kDa allergen
suggested that the IgE-binding component of T. putrescen-
tiae displayed high level cross-reactivity of Der p 2.
To evaluate the IgE binding activity of Tyr p 2 and Tyr p
3 in T. putrescentiae-induced IgE-mediated reaction, the
previous 22 sera were used for ELISA IgE inhibition assay.
Immune inhibition was performed after pre-incubation with
either rTyr p 2 or rTyr p 3 (100 μg/ml). The results showed
that there was more inhibition by rTyr p 2 (68.5±19.0%)
than by rTyr p 3 (45.3±20.1%)(Fig. 3).
The Relationship of IgE Antibody Titers, Sequence
Homology, and 3D Structure Prediction Between rTyr p 2
and rDer p 2
A total of 30 sera from T. putrescentiae sensitive allergic
rhinitis patients were further examined in this experminent.
The results show that the titers of IgE to rTyr p 2 and rDer p
2 were well correlated (R2=0.89; p<0.01) (Fig. 4a), but the
titers of IgE to rTyr p 3 and rDer p 3 were not well correlated
(R2=0.35) (Fig. 4b). The protein sequence homology
between rDer p 2 and rTyr p 2 was 38%, as performed
using the ExPASy server (www.expasy.ch/tools/). Howerver,
the 3D structure predictions of rTyr p 2 and rDer p 2 were
rDer f 1 rDer f 2 rDer p 2 rTyr p 2 rDer p 3 rTyr p 3
B1 – 2+ 3+ 1+ 3+ 2+
B2 1+ 5+ 6+ 1+ 1+ –
B3 3+ 1+ 1+ – – 2+
B4 2+ 5+ 5+ 2+ 1+ –
B5 – – – – – 1+
B6 2+ 3+ 2+ 2+ – 2+
B7 2+ – – – 1+ 3+
B8 – – – – 1+ –
B9 3+ 2+ 2+ 6+ – 1+
B10 – 1+ 1+ 1+ – 1+
B11 – – – – – –
B12 3+ 6+ 6+ 6+ 2+ 1+
B13 1+ – 1+ – 1+ –
B14 1+ 2+ 3+ 3+ 2+ 4+
B15 – 2+ 3+ 1+ – –
B16 – 1+ 2+ 2+ – –
B17 2+ 1+ 1+ 1+ – 1+
B18 – 1+ 1+ 1+ 1+ –
B19 1+ 1+ 1+ 1+ – –
B20 – 1+ 2+ 1+ 1+ –
B21 2+ 1+ 3+ 1+ 3+ –
B22 1+ 1+ 1+ 1+ 2+ –
Positive cases 13 17 18 16 12 10
% 59% 77% 82% 73% 55% 46%
Table II The Titers of
Recombinant Allergen-Specific
IgE in the Sera
Absorbance was measured
at an optical density of
405 nm. –: <0.25; 1+: 0.25∼
0.34; 2+: 0.35∼0.44; 3+: 0.45∼
0.54; 4+: 0.55∼0.64; 5+: 0.65∼
0.74; 6+: 0.75∼0.84
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compared and showed that there was a high degree of
similarity between rDer p 2 and rTyr p 2 (Fig. 5a, b).
Discussion
Sensitization to house dust mites is an important risk
factor for the development of allergic diseases such as
asthma and rhinitis. In our previous study, the prevalence of
sensitization to T. putrescentiae was significantly higher in
elderly subjects (age over 70), while the prevalence of
sensitization to D. pteronyssinus was significantly higher in
young adults (age under 40). Tyrophagus putrescentiae and
D. pteronyssinus sensitization are associated with age
(p=0.02) [21]. Similar results were found in this study;
there were more allergic rhinitis patients sensitized to D.
pteronyssinus than to T. putrescentiae in the young adult
less than 40 years of age. Therefore, a selection bias may
exist. Since all patients in the study were 40 years old or
younger, their possibility to be sensitized to D. pteronyssinus
Fig. 2 Identification of T.
putrescentiae-specific allergenic
components was performed by
immunoblot inhibition analysis
of IgE reactivity by sera from
allergic rhinitis subjects. a Sera
pre-treated with or without D.
pteronyssinus crude extract were
used to identify the specific IgE-
binding components to T.
putrescentiae crude extract. M:
protein marker; Tp crude: crude
extract of T. putrescentiae, B1–
B22: sera from allergic rhinitis
subjects. Triangles: sera pre-
absorbed with 50 μg/ml D.
pteronyssinus crude extract.
Arrows point to the IgE-binding
components of molecular
weights 16 and 26 kDa. b Five
sera from patients who had
positive reactions to the IgE-
binding component of T.
putrescentiae with MWs of 16
and 26 kDa were selected for
further analysis. Lane 1:
recombinant Tyr p 2 allergen,
lane 2: recombinant Tyr p 3
allergen, circles: sera pre-treated
with rDer p 2, squares: sera pre-
treated with rDer p 3
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only and react to T. putrescentiae due to cross-reactivity is
higher compared to what would be expected if older patients
had also been included.
Dermatophagoides pteronyssinus was the most common
house dust mite to which allergic individuals were
sensitized. Among the mite-sensitive subjects, 28% (33/
117) of the subjects were sensitive to both D. pteronyssinus
and T. putrescentiae, indicating that T. putrescentiae, as
well as D. pteronyssinus, could contribute to the allergic
reactions in allergic subjects. Since 97.1% (33/34) of the T.
putrescentiae-sensitive subjects were co-sensitized to D.
pteronyssinus, this could either be due to multiple mite
allergen sensitizations or due to the cross-reaction between
T. putrescentiae and D. pteronyssinus. It has been reported
that there are cross-reactive components among T.
putrescentiae and D. pteronyssinus, and that patients can be
co-sensitized by both mite species [12]. Our previous report
also showed that both house dust mites and storage mites can
be found simultaneously in house dust collected from the
houses of allergic asthmatic patients [18]. However, it has also
been demonstrated that there is limited cross-inhibition
between 15–16 kDa components in T. putrescentiae and D.
pteronyssinus extracts [27]. This discrepancy is probably due
to different patient population selection and a lack of a
purified recombinant allergen preparation.
To differentiate the co-sensitization and cross-reactivity
between T. putrescentiae and D. pteronyssinus, the sera
from skin test positive reactions to T. putrescentiae and D.
pteronyssinus were selected for immunoblot inhibition after
D. pteronyssinus absorption. Group 2 and group 3 allergens
were used to identify the cross-reactivity. Our results
showed that the IgE-binding component with a MW of
16 kDa was absorbed by D. pteronyssinus and rDer p 2.
The titers of specific IgE to rTyr p 2 and rDer p 2 were also
well correlated. These results indicate that the cross-
reactivity between T. putrescentiae and D. pteronyssinus is
mainly due to the group 2 allergens. Although there was
only 38% sequence homology between Tyr p 2 and Der p 2
Fig. 2 (continued)
Fig. 3 The ELISA inhibition study with inhibitor-rTyr p 2 and rTyr p
3 (100 μg/ml) using sera from 22 patients (B1–22). The value of 50%
inhibition is indicated as (broken line). Circles: sera absorbed with
rTyr p 2, squares: sera absorbed with rTyr p 3
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(www.expasy.ch/tools/) (data not shown), there was high
structural homology between these two allergens. Whether
Tyr p 2 and Der p 2 share common IgE binding epitopes
requires further investigation.
Since the titer of specific IgE and its binding activity to
major allergens is related to the severity of allergic reaction,
ELISA was performed to measure the specific IgE binding
activity using recombinant proteins. The results show that
82% and 73% of the subjects' sera were positive to rDer p 2
and rTyr p 2, respectively, and that this IgE binding activity
could be inhibited by rTyr p 2. These results indicate that
rTyr p 2 is the major allergen of T. putrescentiae and may
play a major role in the IgE-mediated hypersensitive reaction
to T. putrescentiae. The IgE-mediated hypersensitivity caused
by group-2 mite allergen might be relevant to the clinical
presentation of allergic rhinitis.
Each allergenic component in the crude extract can vary
from each batch of mite allergen preparation; it is important
to identify the specific allergens from each species. In this
study, although the titers of specific IgE to rTyr p 3 were
low and only 46% subjects were positive to rTyr p 3, there
was non-absorbance by rDer p 3 and poor correlation of the
titers of specific IgE to rDer p 3. These results suggest that
Tyr p 3 is a T. putrescentiae specific allergen, and it could
serve as a good marker for the identification of T.
putrescentiae allergy.
In conclusion, most of our young adult allergic rhinitis
patients were sensitized to either D. pteronyssinus or T.
putrescentiae. Although there was cross-reactivity and co-
sensitization, T. putrescentiae-sensitive patients were not
uncommon, and most of the T. putrescentiae-sensitive
patients were also co-sensitive to D. pteronyssinus. Tyr p 2
was the major allergenic component and might have cross-
reactivity with Der p 2. Tyr p 3 was the major non-cross
Fig. 5 The 3D tertiary structure prediction of rDer p 2 (a) and rTyr p
2 (b)
Fig. 4 The relationship between the titer of IgE antibodies to group 2 or
group 3 allergens of T. putrescentiae and D. pteronyssinus (a).
Relationship between antibodies to rTyr p 2 and rDer p 2 by ELISA.
Absorbance was measured at an optical density of 405 nm. Correlation
coefficient (R2=0.89; p≤0.01) (b). Relationship between antibodies to
rTyr p 3 and Der p 3 by ELISA. Correlation coefficient (R2=0.35)
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reactive component and might serve as a T. putrescentiae-
specific allergen. These observations could help us to better
understand the reasons for co-sensitization to D. pteronyssi-
nus and T. putrescentiae in Taiwan. The diagnosis could be
accurate (dual sensitization), but the reason may be cross-
reactive, and therefore, treatment for both species may not be
needed.
Acknowledgements This study was supported by grant (TCVGH-
977310C) from Taichung Veterans General Hospital and grant
(NSC97-2320-B010-008-MY3) from the National Science Council
of Taiwan. The authors sincerely appreciate the assistance of the
TCVGHAGE research group and Biostatistics Task Force of Taichung
Veterans General Hospital, Taichung, Taiwan.
References
1. Simplicio EC, Silva DA, Braga IA, Sopelete MC, Sung SJ,
Taketomi EA. Mite and pet allergen exposure in hotels in
Uberlandia, Midwestern Brazil. Indoor Air. 2007;17:278–83.
2. Cates EC, Fattouh R, Johnson JR, Llop-Guevara A, Jordana M.
Modeling responses to respiratory house dust mite exposure.
Contrib Microbiol. 2007;14:42–67.
3. Murray CS, Woodcock A, Custovic A. The role of indoor allergen
exposure in the development of sensitization and asthma. Curr
Opin Allergy Clin Immunol. 2001;1:407–12.
4. Diette GB, McCormack MC, Hansel NN, Breysse PN, Matsui E.
Environmental issues in managing asthma. Respir Care.
2008;53:602–15.
5. Bush RK. Indoor allergens, environmental avoidance, and allergic
respiratory disease. Allergy Asthma Proc. 2008;29:575–9.
6. Arlian LG, Morgan MS. Biology, ecology, and prevalence of dust
mites. Immunol Allergy Clin North Am. 2003;23:443–68.
7. Fernandez-Caldas E, Iraola V, Carnes J. Molecular and biochemical
properties of storage mites (except Blomia species). Protein Pept Let.
2007;14:954–9.
8. Thomas WR, Smith WA, Hales B. The allergenic specificities of
the house dust mite. Chang Gung Med J. 2004;27:563–9.
9. Yi FC, Shek LP, Cheong N, Chua KY, Lee B. Molecular cloning
of Blomia tropicalis allergens—a major source of dust mite
allergens in the tropics and subtropics. Inflamm Allergy Drug
Targets. 2006;5:261–6.
10. Kondreddi PK, Elder BL, Morgan MS, Vyszenski-Moher DL,
Arlian L. Importance of sensitization to Tyrophagus putrescentiae
in the United States. Ann Allergy Asthma Immunol. 2006;96:124.
11. Vidal C, Boquete O, Gude F, Rey J, Meijide LM, Fernández-Merino
MC, et al. High prevalence of storage mite sensitization in a general
adult population. Allergy. 2004;59:401–5.
12. Park JW, Ko SH, Yong TS, Ree HI, Jeoung BJ, Hong CS. Cross-
reactivity of Tyrophagus putrescentiae with Dermatophagoides
farinae and Dermatophagoides pteronyssinus in urban areas. Ann
Allergy Asthma Immunol. 1999;83:533–9.
13. Liao EC, Hsu EL, Tsai JJ, Ho CM. Immunologic characterization
and allergenicity of recombinant Tyr p 3 allergen from the storage
mite Tyrophagus putrescentiae. Int Arch Allergy Immunol.
2009;150:15–24.
14. Tsai JJ, Ho CY, Wang SR. Relationship between nasal resistance
and airway hyperreactivity following nasal provocation with
Dermatophagoides pteronyssinus in allergic rhinitis. Int Arch
Allergy Immunol. 1995;106:286–90.
15. Kam KL, Hsieh KH. Comparison of three in vitro assays for
serum IgE with skin testing in asthmatic children. Ann Allergy.
1994;73:329–36.
16. Thomas WR, Smith WA, Hales BJ, Mills KL, O'Brien RM.
Characterization and immunobiology of house dust mite allergens.
Int Arch Allergy Immunol. 2002;129:1–18.
17. Henszel L, Kuzna-Grygiel W. House dust mites in the etiology of
allergic diseases. Ann Acad Med Stetin. 2006;52:123–7.
18. Tsai JJ, Wu HH, Shen HD, Hsu EL, Wang SR. Sensitization to
Blomia tropicalis among asthmatic patients in Taiwan. Int Arch
Allergy Immunol. 1998;115:144–9.
19. Arlian LG, Geis DP, Vyszenski-Moher DL, Bernstein IL,
Gallagher JS. Antigenic and allergenic properties of the storage
mite Tyrophagus putrescentiae. Int Arch Allergy Immunol.
1984;74:166–71.
20. Eriksson TL, Johansson E, Whitley P, Schmidt M, Elsayed S, van
Hage-Hamsten M. Cloning and characterisation of a group II
allergen from the dust mite Tyrophagus putrescentiae. Eur J
Biochem. 1998;251:443–7.
21. Liao EC, Ho CM, Tsai JJ. The prevalence of Tyrophagus
putrescentiae hypersensitivity in subjects over 70 years of age in
a veterans' nursing home in Taiwan. Int Arch Allergy Immunol.
2010;152:368–77.
22. Smith WA, Chua KY, Kuo MC, Rogers BL, Thomas WR. Cloning
and sequencing of the Dermatophagoides pteronyssinus group III
allergen, Der p III. Clin Exp Allergy. 1994;24:220–8.
23. Tsai JJ, Shen HD, Chua KY. Purification of group 2
Dermatophagoides pteronyssinus allergen and prevalence of its
specific IgE in asthmatics. Int Arch Allergy Immunol.
2000;121:205–10.
24. Cui Y, Zhou P, Peng J, Peng M, Zhou Y, Lin Y, et al. Cloning,
sequence analysis, and expression of cDNA coding for the major
house dust mite allergen, Der f 1, in Escherichia coli. Braz J Med
Biol Res. 2008;41:380–8.
25. Wu CC, Liao EC, Lee MF, Tsai JJ. Augmentation of regulatory T
cells in allergic individuals by recombinant Der f 2 peptide with
fungal immunomodulatory peptide fve. Ann Allergy Asthma
Immunol. 2009;102:216–22.
26. Yoshimura T, Kaneuchi T, Miura T, Kimura M. Kinetic analysis of
the fluorescence reaction of histamine with orthophthalaldehyde.
Anal Biochem. 1987;164:132–7.
27. Johansson E, Johansson SG, Van Hage-Hamsten M. Allergenic
characterization of Acarus siro and Tyrophagus putrescentiae and
their cross-reactivity with Lepidoglyphus destructor and Derma-
tophagoides pteronyssinus. Clin Exp Allergy. 1994;24:743–51.
J Clin Immunol (2010) 30:830–839 839
